For its list, published Aug. 11, GoodRx excluded drugs that have to be administered by a healthcare provider. The prices reflect list prices for the drug’s most common 30-day prescription.
The 20 most expensive drugs based on their monthly list prices:
1. Myalept — $71,306 (Amryt Pharma)
2. Ravicti — $55,341 (Horizon Therapeutics)
3. Mavenclad — $56,954 (EMD Serono)
4. Actimmune — $52,777 (Horizon Therapeutics)
5. Oxervate — $48,498 (Dompé)
6. Takhzyro — $45,464 (Takeda)
7. Juxtapid — $44,714 (Amryt Pharma)
8. Cinryze — $44,141 (Takeda)
9. Chenodal — $42,570 (Retrophin)
10. Gattex — $40,450 (Takeda)
11. H.P. Acthar — $39,864 (Mallinckrodt Pharmaceuticals)
12. Tegsedi — $34,600 (Akcea Therapeutics)
13. Vitrakvi — $32,800 (Bayer Pharmaceuticals)
14. Qinlock — $32,000 (Deciphera Pharmaceuticals)
15. Ayvakit — $32,000 (Blueprint Medicines)
16. Korlym — $31,440 (Corcept Therapeutics)
17. Sovaldi — $28,000 (Gilead)
18. Viekira Pak — $27,773 (AbbVie)
19. Tibsovo — $27,421 (Agios Pharmaceuticals)
20. Cerdelga — $27,300 (Genzyme Corp.)
More articles on pharmacy:
CVS HealthHub rollout resumes
Merck bets on one-shot vaccine
CVS, Walgreens & Costco sued for not filling opioid prescriptions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
